Rebalix
UBS · sheet of 10 September 2026
UBS · sheet of 10 September 2026ETF sheet · official issuer and register data
UBS SXI Real Estate® Funds ETF CHF dis
CH0105994401 · CH0105994401 · CHF · domicile Switzerland
Real estate (REIT)SFDR art. 6
Index tracked: SXI Real Estate® Funds Broad (TR)
- TER
- 0.97%+ trans. 0.01%
- Fund size
- —
- Tracking difference
- −0.77%3-year avg
- 🇮🇹 tax rate
- —white list not published
- Replication
- Physical
- Income
- Distributingannual
Launch 3 Nov 2009 · costs from the KID as of 26 Aug 2026 · 1 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 2 Sept 2026
The investment objective of the sub-fund is to replicate the price and return performance of the SXI Real Estate® Funds Broad (Total Return) gross of fees. As a fund of funds, this sub-fund can invest up to 100% of its assets in other collective investments (target funds) under Swiss law of the type "real estate funds" that are already or are going to be included in the SXI Real Estate® Funds Broad, and in other assets as permitted under the fund contract. Sustainability risks are not systematically incorporated, as they are not part of the index…
Performance since series start (in euro) — base 100
3 Nov 2009 → 8 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
Returns in euro
| 1 year | +1.8% |
| 3 years | +33.0% |
| 5 years | +25.0% |
| 10 years | +74.5% |
| Since series start | +252.2% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 10.11% | 10.27% | 11.93% |
| Max drawdown | −7.73% | −7.73% | −26.76% |
| Sharpe | -0.03 | 0.49 | -0.17 |
| Sortino | -0.05 | 0.69 | -0.23 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · CH0105994401 · CH01059944011
RebalixCH0105994401 · CH0105994401 · sheet of 10 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · fund with dividends reinvested by Rebalix on each ex-date (no issuer total-return series); index from the declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +9.99% | +10.62% | −0.63% |
| 2024 | +16.74% | +17.59% | −0.85% |
| 2023 | +4.19% | +5.03% | −0.84% |
| 2022 | −15.78% | −15.17% | −0.62% |
| 2021 | +5.97% | +7.32% | −1.35% |
Distributions · per share, in CHF
Frequency: annual · last 12 months: 0.00 CHF (0.00% of NAV) · last ex-date 5 Sept 2025
| Year | Payments | Total (CHF) | Dividend yield |
|---|---|---|---|
| 2025 | 1 | 0.1815 | +1.83% |
| 2024 | 1 | 0.168 | +1.94% |
| 2023 | 1 | 0.168 | +1.98% |
| 2022 | 1 | 0.1745 | +1.69% |
| 2021 | 1 | 0.1645 | +1.67% |
Dividend yield: the year’s distributions over the share value (NAV) at the start of the year.
Listing venues
ESMA register (FIRDS) and official exchange lists
UFUL · Börse Hamburg
+ 4 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/CH0105994401
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/CH0105994401
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · CH0105994401 · CH01059944012